Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Pharmacological treatment of dementia: a scoping review of systematic reviews.

van de Glind EM, van Enst WA, van Munster BC, Olde Rikkert MG, Scheltens P, Scholten RJ, Hooft L.

Dement Geriatr Cogn Disord. 2013;36(3-4):211-28. doi: 10.1159/000353892. Epub 2013 Aug 12. Review.

2.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
3.

Treatment of dementia: anything new?

Machado JC, Caramelli P.

Curr Opin Psychiatry. 2006 Nov;19(6):575-80. Review.

PMID:
17012934
4.

Investigational treatment for vascular cognitive impairment.

Birks J, Flicker L.

Expert Opin Investig Drugs. 2007 May;16(5):647-58. Review.

PMID:
17461738
5.

Pharmacological treatment of dementia.

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2. Review.

PMID:
22992546
6.

[Treatment of degenerative dementia disorders--who should be treated?].

Hasselbalch SG, Kampmann JP.

Ugeskr Laeger. 2009 Mar 2;171(10):802-5. Danish.

PMID:
19265606
7.

Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.

Desmidt T, Hommet C, Camus V.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621. Review.

PMID:
27651011
8.

Galantamine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD004746.

PMID:
16437493
9.

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Fioravanti M, Flicker L.

Cochrane Database Syst Rev. 2001;(4):CD003159. Review.

PMID:
11687175
10.

Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.

Masterman D.

Clin Geriatr Med. 2004 Feb;20(1):59-68. No abstract available.

PMID:
15062487
11.

[Antidementia drugs].

Müller-Spahn F, Sollberger D, Wollmer MA.

Ther Umsch. 2009 Jun;66(6):432-40. doi: 10.1024/0040-5930.66.6.432. Review. German.

PMID:
19496039
12.

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.

Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M.

J Alzheimers Dis. 2013;35(2):349-61. doi: 10.3233/JAD-122140. Review.

PMID:
23411693
13.

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression.

Rountree SD, Atri A, Lopez OL, Doody RS.

Alzheimers Dement. 2013 May;9(3):338-45. doi: 10.1016/j.jalz.2012.01.002. Epub 2012 Oct 24.

PMID:
23102979
14.

Memantine for treatment of moderate to severe Alzheimer's disease.

Perras C.

Issues Emerg Health Technol. 2005 Mar;(64):1-4.

PMID:
15762015
15.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

PMID:
21088041
16.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

17.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
18.

Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.

Erkinjuntti T, Román G, Gauthier S.

J Neurol Sci. 2004 Nov 15;226(1-2):63-6. Review.

PMID:
15537522
19.

Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.

Wong CL, Bansback N, Lee PE, Anis AH.

Can J Neurol Sci. 2009 Nov;36(6):735-9.

PMID:
19960752
20.

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M.

Ann Intern Med. 2008 Mar 4;148(5):379-97. Review.

PMID:
18316756

Supplemental Content

Support Center